2021 年第三季度报告 证券代码：688350 证券简称：富淼科技 江苏富淼科技股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 上年同期增 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | | 年初至报告期末 | | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 369,126,938.76 | 21.16 | 1,036,586, ...

Financial Performance - The company reported a total distributable profit of RMB 285,178,578.55 as of December 31, 2020[5]. - The cash dividend represents 47.74% of the net profit attributable to the parent company's shareholders for the year[5]. - The company's operating revenue for 2020 was approximately CNY 1.135 billion, a slight increase of 0.39% compared to CNY 1.130 billion in 2019[21]. - The net profit attributable to shareholders for 2020 was CNY 104.91 million, representing a growth of 23.07% from CNY 85.25 million in 2019[21]. - The net profit after deducting non-recurring gains and losses was CNY 96.01 million, up 16.57% from CNY 82.36 million in the previous year[21]. - The cash flow from operating activities for 2020 was CNY 165.57 million, a decrease of 15.95% compared to CNY 196.99 million in 2019[21]. - The total assets at the end of 2020 were CNY 1.310 billion, an increase of 2.73% from CNY 1.276 billion at the end of 2019[22]. - The net assets attributable to shareholders at the end of 2020 were CNY 970.19 million, reflecting a growth of 7.17% from CNY 905.28 million at the end of 2019[22]. - The basic and diluted earnings per share were CNY 1.15, reflecting a growth of 23.66% year-on-year[25]. - The company's net cash flow from operating activities was CNY 165,574,725.46, which is 157.85% of the net profit for the period[24]. Dividend Policy - A cash dividend of RMB 4.10 per 10 shares (including tax) is proposed, totaling RMB 50,081,500 (including tax) based on a total share capital of 122,150,000 shares[5]. - The cash dividend distribution policy stipulates that at least 10% of the distributable profit should be distributed in cash if the company is profitable[142]. - The company aims to maintain a stable and continuous profit distribution policy to ensure reasonable returns to investors[142]. - The cash dividend for 2020 is proposed to be RMB 4.10 per 10 shares[146]. - The company has not proposed any stock dividends or capital reserve transfers for the year 2020[146]. - The company completed a cash dividend distribution of RMB 40 million for the year 2019[145]. Research and Development - Research and development expenses accounted for 4.28% of operating revenue, a slight decrease from 4.46% in the previous year[23]. - The company has set up multiple R&D centers focusing on polymer and membrane technology, ensuring alignment with market needs and national policies[42]. - The company adheres to a research and development strategy focused on "independent research and development as the mainstay, supported by external collaboration," establishing partnerships with several universities for technology development[43]. - The total R&D investment for the year was approximately ¥48.59 million, representing 4.28% of total revenue, a slight decrease from 4.46% in the previous year[67]. - The company holds a total of 100 authorized patents, including 32 invention patents, reflecting continuous innovation and enhancement of its technology portfolio[65]. Market Position and Strategy - The company focuses on hydrophilic functional polymer products and technologies, serving water-based industries such as water treatment and oil extraction, aiming for green development and ecological protection[35]. - The company is positioned in a growing industry, with the national goal of reducing carbon emissions and promoting ecological civilization, which is expected to drive the growth of the water-soluble polymer and water treatment membrane sectors[45]. - The company actively participates in the establishment of industry standards, having contributed to 12 national/industry standards, with several already in implementation[52]. - The company holds a significant market share in functional monomers, particularly in DMDAAC, and has improved its market position in the papermaking sector in 2020[51]. - The company aims to enhance R&D investment to upgrade its technology center and improve product development capabilities[134]. Operational Efficiency - The company implemented proactive measures during the COVID-19 pandemic to ensure production continuity and market expansion, enhancing operational efficiency[24]. - The company has established a complete industrial chain from key raw materials to core products, enhancing its competitive edge in new product and technology development[76]. - The company is focusing on lean management projects to improve organizational efficiency and long-term competitiveness[82]. - The company achieved significant advancements in water treatment membrane technology, including the development of high-performance PVDF hollow fiber membrane materials[64]. - The company has made significant progress in optimizing production processes based on customer feedback, enhancing product performance and quality[81]. Risks and Challenges - The company faces risks from intensified market competition, particularly in the functional monomer sector, where it competes with multinational chemical companies[98]. - The ongoing impact of the COVID-19 pandemic has created uncertainties that may affect business expansion and accounts receivable recovery[102]. - The company's main raw materials, including acrylonitrile and chloroprene, constitute over 80% of its main business costs, with prices closely linked to crude oil fluctuations, which may impact operating performance[96]. - The company's net accounts receivable at the end of the reporting period was approximately 246.44 million yuan, representing 34.08% of current assets, indicating potential risks related to cash flow and bad debts[100]. - The company is exposed to risks from changes in industry regulations, particularly concerning safety and environmental standards, which could affect normal operations[95]. Future Outlook - The company provided a positive outlook for 2021, projecting a revenue growth of 10% to 12%[152]. - New product launches are expected to contribute an additional $50 million in revenue in 2021[153]. - Market expansion plans include entering three new international markets by Q3 2021[155]. - The company aims to improve operational efficiency, targeting a 5% reduction in costs by the end of 2021[150]. - The company plans to strengthen brand building and market development to increase customer satisfaction and market share[135].

Financial Performance - The company reported a total revenue of RMB 500 million for the first half of 2021, representing a year-on-year increase of 20%[1]. - The company's operating revenue for the first half of 2021 was ¥667,460,031.82, representing a 29.70% increase compared to ¥514,612,992.29 in the same period last year, primarily due to enhanced market development and brand influence[20]. - The net profit attributable to shareholders for the first half of 2021 was ¥62,109,220.49, a 7.90% increase from ¥57,564,233.97 in the previous year[20]. - The net cash flow from operating activities decreased by 49.05% to ¥53,185,810.74 from ¥104,380,331.32 in the same period last year[20]. - The company's total assets increased by 29.37% to ¥1,695,181,381.11 from ¥1,310,341,841.89 at the end of the previous year[21]. - The net assets attributable to shareholders rose by 39.06% to ¥1,349,141,133.65 from ¥970,190,247.08 at the end of the previous year[21]. - Basic earnings per share for the first half of 2021 were ¥0.53, down 15.87% from ¥0.63 in the same period last year[22]. - The net profit excluding non-recurring gains and losses was ¥48,974,432.98, a decrease of 8.19% year-on-year[23]. - The company received government subsidies amounting to ¥12,264,210.77, contributing positively to the financial results[26]. Market Strategy and Expansion - The company expects a revenue growth forecast of 25% for the second half of 2021, driven by new product launches and market expansion strategies[1]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2022[1]. - The company continues to focus on expanding its market presence and enhancing brand recognition as part of its growth strategy[20]. - The company is positioned in the water-soluble polymer and water treatment membrane market, which is expected to grow due to increasing environmental regulations and demand for resource recycling[30]. - The national policy aims for a 25% reuse rate of reclaimed water in major cities by 2025, with specific targets for different regions, which supports the company’s market potential[36]. Research and Development - Research and development expenses increased by 30% to RMB 50 million, focusing on new technologies in water treatment solutions[1]. - The research and development expenditure accounted for 4.53% of operating revenue, slightly increasing from 4.51% in the previous year[22]. - The company has multiple R&D centers focusing on polymer and membrane technology, emphasizing independent research and external collaboration[47]. - The company has undertaken several national and provincial research projects, including the "Liquid Water-Soluble Polymer Concentrate (CAPC) Project" and "Oil-in-Water Polyacrylamide Emulsion Technology Development"[48]. - The company has developed a functional monomer manufacturing technology with a conversion rate and selectivity of over 99.9% for acrylamide production, achieving high product yield and purity[50]. - The company has developed a new organic sludge dewatering technology that utilizes high-charge, high-channel organic water-soluble polymer dewatering agents[53]. - The company is currently working on 14 R&D projects, focusing on water-soluble polymer manufacturing and water treatment membrane technology[54]. Operational Efficiency and Cost Management - The company has implemented new strategies to enhance operational efficiency, aiming for a 15% reduction in production costs by the end of 2021[1]. - The procurement model combines market-based and strategic purchasing, maintaining long-term agreements with quality suppliers to stabilize supply and control costs[44]. - The production model for functional monomers and water-soluble polymers is based on monthly planning, ensuring safety stock while meeting customer orders[44]. - The company is committed to continuous improvement in production efficiency and safety through lean management practices[75]. Environmental Compliance and Sustainability - The company has implemented effective monitoring and treatment of pollution sources, ensuring compliance with national and local emission standards[110]. - The company has committed to zero wastewater discharge through upgraded treatment projects, achieving water reuse[109]. - The company is participating in the national carbon market trading, with a focus on reducing carbon emissions through various measures[115]. - The "All-in-One Thermal Power Cloud" project is expected to reduce carbon dioxide emissions by 6,500 tons annually by improving production efficiency and reducing coal consumption[115]. Risks and Challenges - The company has identified potential risks related to supply chain disruptions and has outlined mitigation strategies in the report[1]. - The company faces risks related to technological updates, core personnel retention, and potential R&D failures that could impact operational performance[79]. - The competitive landscape in the functional monomer and water treatment sectors is intensifying, with significant pressure from established multinational companies[86]. - The ongoing global pandemic and extreme weather events pose uncertainties that could disrupt supply chains and affect business operations[88]. Shareholder Commitments and Governance - The company commits to not transferring or entrusting the management of its pre-IPO shares for 36 months from the date of listing[125]. - The company will publicly disclose any failure to fulfill commitments and apologize to shareholders if it causes losses in securities trading[126]. - The company will ensure compliance with all legal and regulatory requirements regarding shareholder obligations and shareholding changes[151]. - The company will conduct profit distributions annually, with the possibility of mid-term dividends based on profitability and funding needs[172].

Financial Performance - Operating revenue rose by 36.76% to CNY 313,304,737.60 year-on-year[5] - Net profit attributable to shareholders increased by 30.23% to CNY 34,265,986.23 compared to the same period last year[5] - Basic and diluted earnings per share increased by 6.90% to CNY 0.31[5] - The company's revenue for Q1 2021 reached RMB 313,304,737.60, representing a 36.76% increase compared to RMB 229,084,196.31 in the same period last year[14] - The net profit for Q1 2021 was RMB 34,264,351.60, a 30.27% increase from RMB 26,301,791.30 year-on-year, driven by revenue growth[15] - Total operating revenue for Q1 2021 reached CNY 313,304,737.60, a 37% increase from CNY 229,084,196.31 in Q1 2020[28] - Net profit for Q1 2021 was CNY 34,264,351.60, representing a 30% increase compared to CNY 26,301,791.30 in Q1 2020[29] Assets and Liabilities - Total assets increased by 32.82% to CNY 1,740,357,780.68 compared to the end of the previous year[5] - The company's total assets as of Q1 2021 amounted to CNY 1,682,515,215.61, compared to CNY 1,255,900,361.19 in the previous year[26] - The company's equity attributable to shareholders increased to ¥1,371,379,399.39 from ¥970,190,247.08, reflecting a growth of 41.38%[22] - Total liabilities for Q1 2021 were CNY 314,283,843.37, an increase from CNY 285,923,503.49 in Q1 2020[26] Cash Flow - Cash flow from operating activities decreased by 91.04% to CNY 3,533,621.11 compared to the previous year[5] - The net cash flow from operating activities decreased by 91.04% to ¥3,533,621.11 compared to ¥39,435,406.25 in the same period last year, primarily due to increased tax expenses and employee compensation[16] - The net cash flow from investing activities was -¥258,784,789.42, a significant increase in outflow compared to -¥61,310,166.99 in the previous year, mainly due to an increase in structured deposits[16] - The net cash flow from financing activities improved to ¥386,598,073.65 from -¥731,161.40, attributed to funds raised from the initial public offering[16] Research and Development - R&D expenses accounted for 4.19% of operating revenue, an increase of 0.06 percentage points[6] - Research and development expenses for Q1 2021 were RMB 13,112,243.46, up 38.55% from RMB 9,463,948.43, indicating a return to normal project timelines after pandemic-related delays[14] - Research and development expenses increased to ¥8,413,932.73 in Q1 2021, a 81.5% rise from ¥4,638,001.86 in Q1 2020[30] Shareholder Information - The total number of shareholders reached 8,630 at the end of the reporting period[9] - The largest shareholder, Jiangsu Feixiang Chemical Co., Ltd., holds 48.66% of the shares[10] Other Financial Metrics - The weighted average return on equity decreased by 0.08 percentage points to 2.78%[5] - The company reported non-recurring gains of CNY 7,144,467.98 during the period[8] - Other income surged by 13626.89% to RMB 5,697,263.91, mainly from increased government subsidies unrelated to regular business activities[15] - The company's operating costs increased by 41.99% to RMB 242,886,115.59, primarily due to rising raw material prices[14] - The company reported a gross profit of CNY 33,373,527.90 for Q1 2021, compared to a gross loss of CNY 31,231,162.22 in Q1 2020[28]

Financial Performance - The company reported a total distributable profit of RMB 285,178,578.55 as of December 31, 2020[5]. - The proposed cash dividend is RMB 4.10 per 10 shares, totaling RMB 50,081,500, which represents 47.74% of the net profit attributable to shareholders[5]. - The company's operating revenue for 2020 was CNY 1,134,782,996.12, representing a 0.39% increase compared to CNY 1,130,330,548.61 in 2019[21]. - The net profit attributable to shareholders for 2020 was CNY 104,910,487.86, a 23.07% increase from CNY 85,245,957.02 in 2019[21]. - The net profit after deducting non-recurring gains and losses was CNY 96,012,263.43, reflecting a 16.57% increase from CNY 82,362,469.03 in 2019[21]. - The cash flow from operating activities for 2020 was CNY 165,574,725.46, a decrease of 15.95% compared to CNY 196,994,483.69 in 2019[21]. - The total assets at the end of 2020 were CNY 1,310,341,841.89, a 2.73% increase from CNY 1,275,510,964.99 at the end of 2019[22]. - The net assets attributable to shareholders at the end of 2020 were CNY 970,190,247.08, which is a 7.17% increase from CNY 905,279,759.22 at the end of 2019[22]. - The basic and diluted earnings per share were both ¥1.15, reflecting a growth of 23.66% year-on-year[25]. - The company's operating income for the reporting period was 1,134.78 million yuan, a slight increase of 0.39% compared to the previous year, while operating costs rose by 0.09% to 849.77 million yuan[106][107]. Research and Development - Research and development expenses accounted for 4.28% of operating revenue, a slight decrease from the previous year's 4.46%[23]. - The total R&D investment for the year was approximately ¥48.59 million, representing 4.28% of total revenue, a decrease of 3.62% from the previous year[67]. - The company maintained 102 R&D personnel, accounting for 13.23% of total employees, with an average salary of RMB 182,777.80[73]. - The company has set up multiple R&D centers focusing on polymer and membrane technology, ensuring alignment with market needs and strategic goals[42]. - The company adheres to a research and development strategy focused on "independent research and development as the mainstay, supported by external collaboration," establishing partnerships with several universities for technology development[43]. - The company has undertaken multiple national and provincial research projects, enhancing its core technologies in functional monomer and water-soluble polymer production[59]. - A total of 16 research projects were ongoing during the reporting period, with 42 new patents granted, including 14 invention patents[65]. - The company holds a total of 100 authorized patents, including 32 invention patents, reflecting continuous innovation[65]. Market and Product Development - The company focuses on hydrophilic functional polymer products and technologies, serving water-based industries such as water treatment and oil extraction, aiming for green development and ecological protection[35]. - The main products include functional monomers, water-soluble polymers, and water treatment membranes, with a complete industrial chain from raw materials to application technology services[36]. - The company is actively involved in the development of high-performance and new products to meet the increasing demands from downstream industries[46]. - The market for water-soluble polymers is characterized by high competition primarily on price, with a growing demand for high-performance products due to downstream industry upgrades[46]. - The company has successfully secured significant supply orders in the Taiwanese market for its membrane products, indicating a breakthrough in business development[51]. - The company aims to enhance production efficiency and resource recycling in industrial water processes, contributing to environmental sustainability[35]. - The company is focusing on the development of new functional monomers and water-soluble polymer applications, indicating a strong market position[68]. Corporate Governance and Compliance - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report[4]. - The company emphasizes the importance of improving corporate governance and compliance with regulatory requirements to enhance management levels[140]. - The company commits to avoiding and minimizing related party transactions with its controlled entities[164]. - The company guarantees that any profits from violations of commitments will be returned to the company[160]. - The company will comply with all legal and regulatory requirements regarding share reduction[161]. Risks and Challenges - The company has detailed various operational risks and corresponding countermeasures in the report[4]. - The company faces risks from fluctuations in the prices of key raw materials, which account for over 80% of its main business costs, particularly due to their strong correlation with crude oil prices[96][97]. - The company is exposed to risks from intensified market competition, particularly in the functional monomer and water treatment chemical sectors, where it competes with multinational corporations[98][99]. - The company's future performance may be adversely affected by changes in industry regulations and macroeconomic conditions, particularly in relation to environmental policies and market demand[95][103]. Future Outlook - The company provided a positive outlook for 2021, projecting a revenue growth of 20%[153]. - New product launches are expected to contribute an additional $50 million in revenue in the next fiscal year[154]. - The company plans to maintain a dividend payout ratio of 40% of its net income for the upcoming fiscal year[152]. - The management team emphasized the importance of sustainability initiatives, targeting a 25% reduction in carbon emissions by 2025[153]. - The company plans to strengthen brand building and market development to increase customer satisfaction and market share in core products[135].